140 related articles for article (PubMed ID: 26776460)
1. Differential expression of HLA-G and ILT-2 receptor in human tuberculosis: Localized versus disseminated disease.
Saurabh A; Thakral D; Mourya MK; Singh A; Mohan A; Bhatnagar AK; Mitra DK; Kanga U
Hum Immunol; 2016 Sep; 77(9):746-53. PubMed ID: 26776460
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting HLA-G restores IFN-γ and TNF-α producing T cell in pleural Tuberculosis.
Saurabh A; Chakraborty S; Kumar P; Mohan A; Bhatnagar AK; Rishi N; Mitra DK
Tuberculosis (Edinb); 2018 Mar; 109():69-79. PubMed ID: 29559123
[TBL] [Abstract][Full Text] [Related]
3. Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary.
Schwich E; Hò GT; LeMaoult J; Bade-Döding C; Carosella ED; Horn PA; Rebmann V
Front Immunol; 2020; 11():2046. PubMed ID: 32973812
[TBL] [Abstract][Full Text] [Related]
4. HLA-G and HLA-E in patients with juvenile idiopathic arthritis.
Prigione I; Penco F; Martini A; Gattorno M; Pistoia V; Morandi F
Rheumatology (Oxford); 2011 May; 50(5):966-72. PubMed ID: 21186170
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer.
Chen QY; Chen YX; Han QY; Zhang JG; Zhou WJ; Zhang X; Ye YH; Yan WH; Lin A
Front Immunol; 2021; 12():679090. PubMed ID: 34054869
[TBL] [Abstract][Full Text] [Related]
6. Differential expression and predictive value of monocyte scavenger receptor CD163 in populations with different tuberculosis infection statuses.
Liu Q; Ou Q; Chen H; Gao Y; Liu Y; Xu Y; Ruan Q; Zhang W; Shao L
BMC Infect Dis; 2019 Nov; 19(1):1006. PubMed ID: 31779590
[TBL] [Abstract][Full Text] [Related]
7. Identification of CD244-expressing myeloid-derived suppressor cells in patients with active tuberculosis.
Yang B; Wang X; Jiang J; Zhai F; Cheng X
Immunol Lett; 2014; 158(1-2):66-72. PubMed ID: 24333340
[TBL] [Abstract][Full Text] [Related]
8. Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients.
Rohn H; Schramm S; Pansikaki K; Jansen S; Hendriks C; Platte M; Konik MJ; Dolff S; Wilde B; Kordelas L; Trilling M; Krawczyk A; Horn PA; Witzke O; Rebmann V
Hum Immunol; 2023 Aug; 84(8):393-400. PubMed ID: 36925435
[TBL] [Abstract][Full Text] [Related]
9. Expression of HLA-DR and KLRG1 enhances the cytotoxic potential and cytokine secretion capacity of CD3
Yang Y; Shi H; Zhou Y; Zhou Y
Int Immunopharmacol; 2024 May; 133():112115. PubMed ID: 38652959
[TBL] [Abstract][Full Text] [Related]
10. Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT-4/FasL-mediated pathways.
Naji A; Durrbach A; Carosella ED; Rouas-Freiss N
Hum Immunol; 2007 Apr; 68(4):233-9. PubMed ID: 17400057
[TBL] [Abstract][Full Text] [Related]
11. A Phenotypic Analysis of Regulatory T Cells and Uterine NK Cells from First Trimester Pregnancies and Associations with HLA-G.
Djurisic S; Skibsted L; Hviid TV
Am J Reprod Immunol; 2015 Nov; 74(5):427-44. PubMed ID: 26293482
[TBL] [Abstract][Full Text] [Related]
12. Tumour necrosis factor-alpha and nitric oxide response in different categories of tuberculosis patients.
Chakraborty U; Goswami A; Saha S; Mukherjee T; Dey SK; Majumdar S; Pal NK
Int J Tuberc Lung Dis; 2013 Apr; 17(4):505-10. PubMed ID: 23485383
[TBL] [Abstract][Full Text] [Related]
13. Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients.
Własiuk P; Tomczak W; Zając M; Dmoszyńska A; Giannopoulos K
Hum Immunol; 2013 Dec; 74(12):1592-7. PubMed ID: 23994589
[TBL] [Abstract][Full Text] [Related]
14. Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment.
Wu D; Kuiaste I; Moreau P; Carosella E; Yotnda P
Oncotarget; 2015 Nov; 6(35):37385-97. PubMed ID: 26460949
[TBL] [Abstract][Full Text] [Related]
15. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts.
Zhang W; Liang S; Wu J; Horuzsko A
Transplantation; 2008 Oct; 86(8):1125-34. PubMed ID: 18946352
[TBL] [Abstract][Full Text] [Related]
16. Cytokine gene polymorphisms in Colombian patients with different clinical presentations of tuberculosis.
Henao MI; Montes C; París SC; García LF
Tuberculosis (Edinb); 2006 Jan; 86(1):11-9. PubMed ID: 15925543
[TBL] [Abstract][Full Text] [Related]
17. Plasma soluble human leukocyte antigen-G expression is a potential clinical biomarker in patients with hepatitis B virus infection.
Shi WW; Lin A; Xu DP; Bao WG; Zhang JG; Chen SY; Li J; Yan WH
Hum Immunol; 2011 Nov; 72(11):1068-73. PubMed ID: 21762747
[TBL] [Abstract][Full Text] [Related]
18. FoxP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis.
Sharma PK; Saha PK; Singh A; Sharma SK; Ghosh B; Mitra DK
Am J Respir Crit Care Med; 2009 Jun; 179(11):1061-70. PubMed ID: 19246720
[TBL] [Abstract][Full Text] [Related]
19. Recruitment of Th1 effector cells in human tuberculosis: hierarchy of chemokine receptor(s) and their ligands.
Saha PK; Sharma PK; Sharma SK; Singh A; Mitra DK
Cytokine; 2013 Jul; 63(1):43-51. PubMed ID: 23643185
[TBL] [Abstract][Full Text] [Related]
20. Increased frequency of ILT2-expressing CD56(dim)CD16(+) NK cells correlates with disease severity of pulmonary tuberculosis.
Wang X; Meng X; Zheng Y; Jiang J; Yang B; Liu Y; Zhai F; Cheng X
Tuberculosis (Edinb); 2014 Sep; 94(5):469-74. PubMed ID: 24909369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
